GlassScriptPhysician profile
David J Matthews
NPI 1588775423
$4,544.82
in general payments reported to CMS, 2019-2025
19 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $150 · 2021: $492 · 2022: $802 · 2023: $893 · 2024: $758 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,688.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,137.72 | 2019-2025 | Total30, Tryptyr |
| Coopervision INC. | $495.46 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $364.18 | 2019-2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $346.37 | 2020-2025 | Cequa |
| Biotissue Holdings INC. | $300.88 | 2022-2025 | |
| Abbvie INC. | $269.58 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $242.42 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $223.83 | 2024-2025 | Acthar |
| Sight Sciences, INC. | $209.56 | 2023-2024 | Omni Surgical System |
| Oyster Point Pharma, INC. | $129.45 | 2022-2023 | Tyrvaya |
| Maculogix, INC. | $126.34 | 2021 | |
| Bausch & Lomb Americas INC. | $125.00 | 2022 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $124.02 | 2021 | |
| Lkc Technologies, INC. | $97.65 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $78.95 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Allergan, INC. | $75.72 | 2021 | |
| Dompe US, INC. | $57.28 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.